Founded in 1955, Mylan is a pharmaceutical laboratory specializing in generic drugs. Its therapeutic areas concern: allergy, oncology, cardiology-angiology, dermatology, diabetes-nutrition-metabolism, pain and fever, gynecology-obstetrics, immunology, inflammation, etc.
Mylan is a brand of generic drugs headquartered in Saint-Priest (French headquarters and EMEA (Europe, Middle East, Africa). Mylan Laboratories Inc. focuses on the distribution of generic drugs. It is a brand based in the United States, headquartered in Canonsburg, PA. It has numerous production sites in several states in the United States. The company known as Mylan Medical , operates the products of the companies Abbott Product and Meda, which it acquired respectively in 2014 and 2016.
Every day in France, millions of people help their loved ones get through the disease. Whether it is for members of their family, friends or colleagues, they do not hesitate to give of their time, their attention and their benevolence to help them, especially when the disease leads to a loss of autonomy. .
Mylan knows how valuable their contribution is. It is common for patients to feel lonely and helpless in the face of the disease. In this context, Mylan, inspired by caregivers, knows how much every gesture counts.
With a range of nearly 600 drugs, including branded drugs, generics and health products available without a prescription, Mylan today covers nearly 90% of therapeutic areas.
Mylan develops and distributes over a thousand references to contribute to public health. Its range of drugs covers the majority of therapeutic areas for the treatment of various pathologies. Healthcare professionals and patients trust it thanks to its high quality and perfectly packaged products. The laboratory's drug sales figures and the minimum number of returns show its notoriety in the field of pharmaceuticals and drug distribution.
Mylan laboratories design high quality generic drugs, the formulation of which is bioequivalent to the originator treatments which are at their origin. All Mylan medicines are designed, developed and manufactured according to the requirements of Good Manufacturing Practices (GMP) established by the European Commission. In addition to regular and regulatory inspections, 40 internal auditors check around 300 sites per year. All the raw materials (active ingredients and excipients) used in Mylan medicines are therefore subject to strictly established and scrupulously observed control procedures.
Mylan supports the patient throughout their care journey by offering solutions for prevention, screening, and up to treatment compliance.
